-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Biocryst Pharmaceuticals Inc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2012 to Q1 2024.
- Biocryst Pharmaceuticals Inc Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $306K, a 24.4% decline year-over-year.
- Biocryst Pharmaceuticals Inc annual Depreciation, Depletion and Amortization for 2023 was $1.66M, a 15.2% increase from 2022.
- Biocryst Pharmaceuticals Inc annual Depreciation, Depletion and Amortization for 2022 was $1.44M, a 84.9% increase from 2021.
- Biocryst Pharmaceuticals Inc annual Depreciation, Depletion and Amortization for 2021 was $777K, a 3.88% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)